Molecular Signatures in Inflammatory Skin Disease
Recruiting now
Conditions studied: Atopic Dermatitis, Psoriasis
In brief
This pilot project intends to examine the utility of a systems medicine approach to identify regulatory networks and their perturbation in psoriasis and atopic dermatitis, and to obtain a comprehensive perspective on disease and disease control by integrating and modelling data across multiple cellular levels and time following specific blockade of single pathophysiological factors through use of licensed biologics during routine care as systems biology challenge. To this end, ultra-deep phenotyping and prospective molecular characterization in short time-intervals and different disease equilibrium states will be carried out in targeted small sets of patients. The different layers and types of clinical and molecular information will then be integrated (integrative personal omics profiling iPOP) for generating insights into disease pathways and for extraction of molecular signatures that correspond to clinical severity scores. It will provide a good starting point for planning future trials aimed at identifying biological patterns useful for guiding targeted treatment.
Key facts
- Study ID
- NCT03358693
- Run by
- Prof. Dr. Stephan Weidinger
- People needed
- 300
- Starts
- 2017-01-20
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2025-07-22
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ability to provide written informed consent and comply with the protocol
- Dermatologist-diagnosed chronic inflammatory skin disease
- Subject receives systemic therapy within routine care (in-label use of biologics)
You may not qualify if…
- Subject is unable to provide written informed consent or comply with the protocol.
- Having used immunosuppressive/immunomodulating therapy or phototherapy within 4 weeks before the baseline visit.
- Treatment of selected skin areas to be examined with topical corticosteroid or topical calcineurin inhibitor within 1 week before the baseline visit.
Where it is running
- Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel — Kiel, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.